Entry Detail



General Information

Database ID:exR0000489
RNA Name:ALDH4A1
RNA Type:mRNA
Chromosome:chr1
Starnd:-
Coordinate:
Start Site(bp):18871430End Site(bp):18902724
External Links:ENSG00000159423



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
DDI2
chr1
15617458
15669044
+
LIN28A
chr1
26410817
26429728
+
EIF5
chr14
103333544
103345025
+
RPL7A
chr9
133348218
133351426
+
SLC39A1
chr1
153959099
153968184
-
GRB2
chr17
75318076
75405709
-
RPL23
chr17
38847860
38853764
-
ERBB2
chr17
39687914
39730426
+
CASP7
chr10
113679162
113730907
+
METTL16
chr17
2405562
2511891
-
SERF2
chr15
43777087
43802589
+
ESPL1
chr12
53268299
53293638
+
SBF1
chr22
50445000
50475035
-
ACTB
chr7
5527148
5563784
-
OSBPL9
chr1
51577179
51798427
+
HLA-DRB1
chr6
32578769
32589848
-
EXOSC7
chr3
44975241
45036066
+
DCTN1
chr2
74361154
74392087
-
HDHD5
chr22
17137511
17165287
-
RHNO1
chr12
2876258
2889524
+
ZDHHC16
chr10
97446170
97457370
+
EIF3H
chr8
116642130
116766925
-
BCAM
chr19
44809071
44821421
+
FRAS1
chr4
78057323
78544269
+
NKTR
chr3
42600655
42648735
+
TUBA1A
chr12
49184795
49189080
-
EEF1B2
chr2
206159585
206162928
+
SIGIRR
chr11
405716
417455
-
FUS
chr16
31180110
31194871
+
CTNNBIP1
chr1
9848276
9910336
-
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AD000090.1
chr19
35557956
35581954
+
AL022311.1
chr22
37876148
37895563
+
LINC01641
chr1
227393554
227431035
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.